These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 15156439)

  • 21. Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity.
    Rybak MJ; Abate BJ; Kang SL; Ruffing MJ; Lerner SA; Drusano GL
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1549-55. PubMed ID: 10390201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aminoglycoside-induced ototoxicity.
    Selimoglu E
    Curr Pharm Des; 2007; 13(1):119-26. PubMed ID: 17266591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circadian variations in serum levels and the renal toxicity of aminoglycosides in patients.
    Prins JM; Weverling GJ; van Ketel RJ; Speelman P
    Clin Pharmacol Ther; 1997 Jul; 62(1):106-11. PubMed ID: 9246024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative study by scanning electron microscopy on vestibular toxicities of dibekacin, ribostamycin, and other aminoglycoside antibiotics in guinea pigs.
    Sato K; Saito T; Matsuhira T
    Int J Clin Pharmacol Ther Toxicol; 1983 Mar; 21(3):109-14. PubMed ID: 6602100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aminoglycosides: a practical review.
    Gonzalez LS; Spencer JP
    Am Fam Physician; 1998 Nov; 58(8):1811-20. PubMed ID: 9835856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenously delivered aminoglycoside antibiotics, tobramycin and amikacin, are not ototoxic in mice.
    Ogier JM; Lockhart PJ; Burt RA
    Hear Res; 2020 Feb; 386():107870. PubMed ID: 31864009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome of patients treated by an aminoglycoside pharmacokinetic dosing service.
    Sveska KJ; Roffe BD; Solomon DK; Hoffmann RP
    Am J Hosp Pharm; 1985 Nov; 42(11):2472-8. PubMed ID: 4073064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and renal toxicity of one daily dose of amikacin versus conventional dosage regime.
    Guadalupe Vásquez-Mendoza M; Vargas-Origel A; Del Carmen Ramos-Jiménez A; Aguilar-Orozco G; Romero-Gutiérrez G
    Am J Perinatol; 2007 Feb; 24(2):141-6. PubMed ID: 17304422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aminoglycoside toxicity in neonates: something to worry about?
    Kent A; Turner MA; Sharland M; Heath PT
    Expert Rev Anti Infect Ther; 2014 Mar; 12(3):319-31. PubMed ID: 24455994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Vestibulometry in prognosis of lesions of the organ of hearing after administration of aminoglycoside antibiotics].
    Bazarov VG; Mishchanchuk NS
    Zh Ushn Nos Gorl Bolezn; 1978; (6):21-7. PubMed ID: 216180
    [No Abstract]   [Full Text] [Related]  

  • 31. Aminoglycoside nephrotoxicity.
    Swan SK
    Semin Nephrol; 1997 Jan; 17(1):27-33. PubMed ID: 9000547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hearing loss and vestibular dysfunction among children with cancer after receiving aminoglycosides.
    Chen KS; Bach A; Shoup A; Winick NJ
    Pediatr Blood Cancer; 2013 Nov; 60(11):1772-7. PubMed ID: 23788258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [In the search for effective and safe dose of amikacin in patients with chronic kidney disease].
    Gomółka M; Szamotulska K; Rymarz A; Brodowska-Kania D; Dubchak I; Piechota W; Jurkiewicz D; Niemczyk S
    Pol Merkur Lekarski; 2014 Apr; 36(214):240-4. PubMed ID: 24868895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-protection against aminoglycoside ototoxicity in guinea pigs.
    Oliveira JA; Canedo DM; Rossato M; Andrade MH
    Otolaryngol Head Neck Surg; 2004 Sep; 131(3):271-9. PubMed ID: 15365547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Threshold doses in ototoxicity].
    Federspil P
    HNO; 1984 Oct; 32(10):417-8. PubMed ID: 6334677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proper use of aminoglycosides.
    Yoshikawa TT
    Am Fam Physician; 1980 May; 21(5):125-30. PubMed ID: 7377070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of cochlear and vestibular functions of patients treated by dibekacin in an E.N.T. unit].
    Uziel A; Goubert JL
    Nouv Presse Med; 1982 Nov; 11(46):3456-8. PubMed ID: 6984174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continuous or repeated prolonged cisplatin infusions in children: a prospective study on ototoxicity, platinum concentrations, and standard serum parameters.
    Lanvers-Kaminsky C; Krefeld B; Dinnesen AG; Deuster D; Seifert E; Würthwein G; Jaehde U; Pieck AC; Boos J
    Pediatr Blood Cancer; 2006 Aug; 47(2):183-93. PubMed ID: 16302218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aminoglycoside induced ototoxicity.
    Guthrie OW
    Toxicology; 2008 Jul; 249(2-3):91-6. PubMed ID: 18514377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ototoxicity of aminoglycoside antibiotics by rapid intravenous injection (author's transl)].
    Ohtani I; Ohtsuki K; Aikawa T; Takenaka M; Omata T; Ouchi J; Saito T
    Nihon Jibiinkoka Gakkai Kaiho; 1980 Nov; 83(11):1482-90. PubMed ID: 7277075
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.